Oppenheimer Issues Pessimistic Forecast for Nutrien (NYSE:NTR) Stock Price

Nutrien (NYSE:NTR - Get Free Report) had its price objective cut by Oppenheimer from $60.00 to $58.00 in a research report issued on Tuesday,Benzinga reports. The firm presently has an "outperform" rating on the stock. Oppenheimer's price target points to a potential upside of 7.38% from the stock's current price.

A number of other research firms have also issued reports on NTR. Royal Bank of Canada reissued an "outperform" rating and issued a $60.00 target price on shares of Nutrien in a report on Monday, February 24th. Wells Fargo & Company increased their price target on shares of Nutrien from $53.00 to $56.00 and gave the stock an "equal weight" rating in a report on Friday, February 21st. BNP Paribas upgraded Nutrien to a "strong-buy" rating in a research report on Wednesday, April 9th. UBS Group reduced their price target on Nutrien from $54.00 to $52.00 and set a "neutral" rating for the company in a report on Wednesday, April 16th. Finally, Barclays lifted their price target on Nutrien from $56.00 to $59.00 and gave the company an "equal weight" rating in a research note on Wednesday, March 5th. Two analysts have rated the stock with a sell rating, five have assigned a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $59.27.

Nutrien Price Performance

NTR stock opened at $54.02 on Tuesday. The company has a current ratio of 1.27, a quick ratio of 0.82 and a debt-to-equity ratio of 0.38. The company has a market capitalization of $26.40 billion, a P/E ratio of 39.43, a PEG ratio of 1.19 and a beta of 0.77. The business has a 50 day simple moving average of $51.12 and a 200-day simple moving average of $49.40. Nutrien has a twelve month low of $43.70 and a twelve month high of $60.87.

Nutrien (NYSE:NTR - Get Free Report) last issued its quarterly earnings results on Wednesday, February 19th. The company reported $0.28 earnings per share for the quarter, missing analysts' consensus estimates of $0.37 by ($0.09). Nutrien had a return on equity of 6.81% and a net margin of 2.62%. The business had revenue of $5.08 billion for the quarter, compared to analyst estimates of $5.09 billion. As a group, equities analysts anticipate that Nutrien will post 3.72 EPS for the current year.

Institutional Trading of Nutrien

A number of hedge funds have recently added to or reduced their stakes in the business. Virtu Financial LLC acquired a new stake in shares of Nutrien during the 3rd quarter worth $815,000. Wilmington Savings Fund Society FSB purchased a new position in Nutrien in the third quarter valued at approximately $2,237,000. Syntax Research Inc. lifted its position in Nutrien by 11.4% during the third quarter. Syntax Research Inc. now owns 64,836 shares of the company's stock valued at $3,116,000 after buying an additional 6,637 shares in the last quarter. CWA Asset Management Group LLC increased its position in shares of Nutrien by 32.1% in the fourth quarter. CWA Asset Management Group LLC now owns 8,815 shares of the company's stock worth $394,000 after acquiring an additional 2,141 shares in the last quarter. Finally, Moody National Bank Trust Division raised its stake in shares of Nutrien by 127.1% in the 4th quarter. Moody National Bank Trust Division now owns 13,698 shares of the company's stock valued at $613,000 after acquiring an additional 7,665 shares during the period. 63.10% of the stock is owned by institutional investors and hedge funds.

Nutrien Company Profile

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.